FierceBiotech· @FierceBiotech · X·· 2026-10-16AI 评分42
AI 导读
前Fierce 15获奖者OMass Therapeutics获得3.1亿美元新融资,距离其成为"英国大型生物科技公司"的目标更近一步。CEO Ros Deegan向Fierce介绍了这家雄心勃勃的生物科技公司的下一步计划。https://www.fiercebiotech.com/biotech/why-omass-310m-series-c-fantastic-milestone-journey-become-britains-big-biotech
正文
With $310 million in fresh funding, former Fierce 15 winner OMass Therapeutics is one step closer to its goal of becoming "Britain's Big Biotech." CEO Ros Deegan tells Fierce what's next for the ambitious biotech. https://www.fiercebiotech.com/biotech/why-omass-310m-series-c-fantastic-milestone-journey-become-britains-big-biotech
来源:FierceBiotech · x.com